Cancer stem cells: Beyond Koch's postulates

Cancer Letters

Volumn 278, Issue 1, 2009, Pages 3-8

  Garcion, Emmanuel ^a,b   Naveilhan, Philippe ^a   Berger, François ^c   Wion, Didier ^c  

^a INSERM   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

Author keywords

Cancer; Cancer stem cell; Koch's postulates; Targeted therapies

Indexed keywords

CANCER RISK; CANCER STEM CELL; CELL FUNCTION; CELL INTERACTION; HUMAN; INFECTION; LOBECTOMY; PRIORITY JOURNAL; SHORT SURVEY; SOLID TUMOR; TUBERCULOSIS; TUMOR XENOGRAFT;

EID: 63449087881     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.09.006     Document Type: Review

References (55)

1. Wicha M.S., Liu S., and Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res. 66 (2006) 1883-1890
2. Tang C., Ang B.T., and Pervaiz S. Cancer stem cell: target for anti-cancer therapy. FASEB J. 21 (2007) 3777-3785
3. Sanchez-Garcia I., Vicente-Duenas C., and Cobaleda C. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?. Bioessays 29 (2007) 1269-1280
4. Smith A. A glossary for stem-cell biology. Nature 441 (2006) 1060
5. Wu C., and Alman B.A. Side population in human cancers. Cancer Lett. 268 (2008) 1-9
6. Kondo T., Setoguchi T., and Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 101 (2004) 781-786
7. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., and Brenner M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 101 (2004) 14228-14233
8. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
9. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
10. O'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2007) 106-110
11. Dalerba P., Dylla S.J., Park I.K., Liu R., Wang X., Cho R.W., Hoey T., Gurney A., Huang E.H., Simeone D.M., Shelton A.A., Parmiani G., Castelli C., and Clarke M.F. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 104 (2007) 10158-10163
12. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988
13. Zhang S., Balch C., Chan M.W., Lai H.C., Matei D., Schilder J.M., Yan P.S., Huang T.H., and Nephew K.P. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 68 (2008) 4311-4320
14. Hill R.P. Identifying cancer stem cells in solid tumors: case not proven. Cancer Res. 66 (2006) 1891-2510
15. Wion D., and Berger F. Cancer stem cells. N. Engl. J. Med. 355 (2006) 2703
16. Kelly P.N., Dakic A., Adams J.M., Nutt S.L., and Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 317 (2007) 337
17. Campbell L.L., and Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution?. Cell Cycle 6 (2007) 2332-2338
18. Rak J. Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis?. Med. Hypotheses 66 (2006) 601-604
19. Adamski D., Mayol J.F., Platet N., Berger F., Herodin F., and Wion D. Effects of Hoechst 33342 on C2C12 and PC12 cell differentiation. FEBS Lett. 581 (2007) 3076-3080
20. Platet N., Mayol J.F., Berger F., Herodin F., and Wion D. Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line. FEBS Lett. 581 (2007) 1435-1440
21. Zheng X., Shen G., Yang X., and Liu W. Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res. 67 (2007) 3691-3697
22. Zhong Y., Zhou C., Ma W., Wang D., Guo S., Su X., and Zhang S. Most MCF7 and SK-OV3 cells were deprived of their stem nature by Hoechst 33342. Biochem. Biophys. Res. Commun. 364 (2007) 338-343
23. Lichtenauer U.D., Shapiro I., Geiger K., Quinkler M., Fassnacht M., Nitschke R., Ruckauer K.D., and Beuschlein F. Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R. Endocrinology 196 (2007) 1314-1322
24. Wang J., Sakariassen P.O., Tsinkalovsky O., Immervoll H., Boe S.O., Svendsen A., Prestegarden L., Rosland G., Thorsen F., Stuhr L., Molven A., Bjerkvig R., and Enger P.O. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 122 (2008) 761-768
25. - tumor-initiating cells in adult human gliomas. Neurosurgery 62 (2008) 505-514
26. - metastatic colon cancer cells initiate tumors. J. Clin. Invest. 118 (2008) 2111-2120
27. R. Koch, Uber bakteriologische Forschung Verhandlung des X Internationalen Medichinischen Congresses, Berlin, 1, 35, August Hirschwald, Berlin, Xth International Congress of Medicine, Berlin, 1890, 1891.
28. Fredericks D.N., and Relman D.A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 9 (1996) 18-33
29. Evans A.S. Causation and disease: the Henle-Koch postulates revisited. Yale J. Biol. Med. 49 (1976) 175-195
30. Isenberg H.D. Pathogenicity and virulence: another view. Clin. Microbiol. Rev. 1 (1988) 40-53
31. Rivers T.M. Viruses and Koch's postulates. J. Bacteriol. 33 (1937) 1-12
32. Valladares Y. Forms of the cancerigenic principle, cell clones, and Koch's postulates. Med. Pharmacol. Exp. Int. J. Exp. Med. 16 (1967) 462-480
33. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., and Fine H.A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9 (2006) 391-403
34. Platet N., Liu S.Y., Atifi M.E., Oliver L., Vallette F.M., Berger F., and Wion D. Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett. 258 (2007) 286-290
35. Axelrod R., Axelrod D.E., and Pienta K.J. Evolution of cooperation among tumor cells. Proc. Natl. Acad. Sci. USA 103 (2006) 13474-13479
36. Heppner G.H. Tumor cell societies. J. Natl. Cancer Inst. 81 (1989) 648-649
37. Joo K.M., Kim S.Y., Jin X., Song S.Y., Kong D.S., Lee J.I., Jeon J.W., Kim M.H., Kang B.G., Jung Y., Jin J., Hong S.C., Park W.Y., Lee D.S., Kim H., and Nam D.H. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab. Invest. 88 (2008) 808-815
38. Heppner G.H. Tumor heterogeneity. Cancer Res. 44 (1984) 2259-2265
39. Laughlin-Drubin M.E., and Munger K. Viruses associated with human cancer. Biochim. Biophys. Acta 178 (2008) 127-150
40. Pardal R., Clarke M.F., and Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3 (2003) 895-902
41. Fidler I.J., Yano S., Zhang R.D., Fujimaki T., and Bucana C.D. The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol. 3 (2002) 53-57
42. Soto A.M., and Sonnenschein C. The somatic mutation theory of cancer: growing problems with the paradigm?. Bioessays 26 (2004) 1097-1107
43. Sonnenschein C., and Soto A.M. Theories of carcinogenesis: an emerging perspective. Semin. Cancer Biol. 18 (2008) 372-377
44. Laconi E. The evolving concept of tumor microenvironments. Bioessays 29 (2007) 738-744
45. Li L., and Neaves W.B. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 66 (2006) 4553-4557
46. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., and Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563
47. Shekhar M.P., Pauley R., and Heppner G. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res. 5 (2003) 130-135
48. Kalluri R., and Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 6 (2006) 392-401
49. Mueller M.M., and Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4 (2004) 839-849
50. Sica A., Allavena P., and Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett. 264 (2008) 204-215
51. Raman D., Baugher P.J., Thu Y.M., and Richmond A. Role of chemokines in tumor growth. Cancer Lett. 256 (2007) 137-165
52. Cegelski L., Marshall G.R., Eldridge G.R., and Hultgren S.J. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 6 (2008) 17-27
53. Albini A., and Sporn M.B. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 7 (2007) 139-147
54. Joyce J.A. Therapeutic targeting of the tumor microenvironment. Cancer Cell 7 (2005) 513-520
55. Nagel R.L. Epistasis and the genetics of human diseases. C. R. Biol. 328 (2005) 606-615